| Literature DB >> 12407516 |
Emma Cattell1, Charles Kelly, Mark R Middleton.
Abstract
CNS involvement is a common feature of metastatic melanoma. Despite this, there is little evidence upon which clinicians can base decisions about treatment. The short prognosis and significant symptoms usually associated with melanoma brain metastases have excluded these patients from clinical trials. In Europe the standard treatment involves whole brain radiotherapy, although selected centers offer other modalities, including surgery, radiosurgery, and chemotherapy. Copyright 2002, Elsevier Science (USA). All rights reserved.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12407516 DOI: 10.1053/sonc.2002.35246
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929